Article

Immune Activation and Candidate Prognostic Marker Discovery in Bladder Cancer: A Preclinical Mouse Study of Recombinant M. smegmatis

2026-08-28

Abstract excerpt

<title>Abstract</title> <p> Bladder cancer has a high risk of recurrence and progression, and additional therapeutic approaches remain needed. We evaluated the antitumor activity of recombinant <italic>Mycobacterium smegmatis</italic> expressing human macrophage migration inhibitory factor and interleukin-7 (rSmeg-hMIF-hIL-7) in a syngeneic subcutaneous MBT-2 bladder cancer mouse model. rSmeg-hMIF-hIL-7 treatm...

Topics

Open a Topic to create a Post that cites this publication.

Uncategorized literature

Identifiers and source

Literature Corpus work: 09c08dac-3336-5a94-b283-a42074e8ed0c
DOI: 10.21203/rs.3.rs-10659022/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest

Immune Activation and Candidate Prognostic Marker Discovery in Bladder Cancer: A Preclinical Mouse Study of Recombinant M. smegmatisDOI 10.21203/rs.3.rs-10659022/v1Read

Defining the transcriptional landscape of infiltrating immune cells in human and mouse bladder cancerSemantic proximity Read

Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responsesSemantic proximity Read

Multiomics analysis of CXCL9+ macrophages in the immunotherapy response of bladder cancerSemantic proximity Read

The urothelial transcriptomic response to interferon gamma predicts T1 recurrence-free and basal/squamous muscle-invasive bladder cancer survival and better targeted strategies for immune checkpoint blockingSemantic proximity Read

Microbial cancer immunotherapy reprograms hematopoiesis to enhance anti-tumor immunitySemantic proximity Read

Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infectionsSemantic proximity Read

Single Cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwaySemantic proximity Read

Treatment of non-muscle invasive bladder cancer with Bacillus Calmette–Guerin (BCG): Biological markers and simulation studiesSemantic proximity Read

Hypoxia and epithelial to mesenchymal transition pathways are enriched in bladder tumor epithelium adjacent to tertiary lymphoid structuresSemantic proximity Read

Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer/STAT3 complex nuclear translocationSemantic proximity Read

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancerSemantic proximity Read

B cell exhaustion associates with poor response to Bacillus Calmette-Guérin immunotherapy in patients with bladder cancerSemantic proximity Read